NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines

Por Tsofack, Serges P, Garand, Chantal, Sereduk, Chris, Chow, Donald, Aziz, Meraj, Guay, David, Yin, Hongwei H, Lebel, Michel
Publicado em 2011

Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab

Por Yuan, Yuan, Kos, Ferdynand J., He, Ting-Fang, Yin, Hongwei H., Li, Mengsha, Hardwick, Nicola, Zurcher, Kathryn, Schmolze, Daniel, Lee, Peter, Pillai, Raju K., Chung, Vincent, Diamond, Don J.
Publicado no Oncoimmunology (2017)

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

Por Zhao, Xingli, Zhang, Zhuoran, Moreira, Dayson, Su, Yu-Lin, Won, Haejung, Adamus, Tomasz, Dong, Zhenyuan, Liang, Yong, Yin, Hongwei H., Swiderski, Piotr, Pillai, Raju K., Kwak, Larry, Forman, Stephen, Kortylewski, Marcin
Publicado no Mol Ther (2018)

Long-term ERK Inhibition in KRAS-mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression

Por Hayes, Tikvah K., Neel, Nicole F., Hu, Chaoxin, Gautam, Prson, Chenard, Melissa, Long, Brian, Aziz, Meraj, Kassner, Michelle, Bryant, Kirsten L., Pierobon, Mariaelena, Marayati, Raoud, Kher, Swapnil, George, Samuel D., Xu, Mai, Wang-Gillam, Andrea, Samatar, Ahmed A., Maitra, Anirban, Wennerberg, Krister, Petricoin, Emanuel F., Yin, Hongwei H., Nelkin, Barry, Cox, Adrienne D., Yeh, Jen Jen, Der, Channing J.
Publicado no Cancer Cell (2015)